• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Tasignia - Artheroscherosis in clinical trials

Anonymous

Guest
Anyone know anything about Novartis holding back information from r & d and the FDA so they could switch as many pts as possible from gleevec before it goes generic.

Just wanting to know after spending thanksgiving in the hospital after femeral bypass surgery???

BASTARDS!!!!
 

<